Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02035813
Title DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Prof. W. Janni
Indications

progesterone-receptor positive breast cancer

estrogen-receptor positive breast cancer

Therapies

Ribociclib

Eribulin

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.